• 復(fù)旦大學(xué)附屬中山醫(yī)院普外科（上海 200032）;

引用本文： 秦新裕,吳文川. MRSA感染的治療. 中國(guó)普外基礎(chǔ)與臨床雜志, 2010, 17(11): 1120-1122. doi: 復(fù)制

版權(quán)信息： ?四川大學(xué)華西醫(yī)院華西期刊社《中國(guó)普外基礎(chǔ)與臨床雜志》版權(quán)所有，未經(jīng)授權(quán)不得轉(zhuǎn)載、改編

1. Chambers HF. The changing epidemiology of Staphylococcus aureus? [J]. Emerg Infect Dis, 2001; 7(2): 178-182.
2. 汪復(fù)， 朱德妹， 胡付品， 等. 2008年中國(guó)CHINET細(xì)菌耐藥性監(jiān)測(cè) [J]. 中國(guó)感染與化療雜志, 2009; 9(5): 321-329.
3. 朱德妹， 汪復(fù)， 張嬰元. 2004年上海地區(qū)細(xì)菌耐藥性監(jiān)測(cè) [J]. 中國(guó)抗感染化療雜志, 2005; 5(4): 195-200.
4. 朱德妹， 張嬰元， 汪復(fù). 2006年上海地區(qū)細(xì)菌耐藥性監(jiān)測(cè) [J]. 中國(guó)感染與化療雜志, 2007; 7(6): 393-399.
5. Hope R, Livermore DM, Brick G, et al. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06 [J]. J Antimicrob Chemother, 2008; 62 Suppl 2: ii65-ii74.
6. 王琳， 時(shí)萍， 丁海燕， 等. 157株MRSA菌株的耐藥調(diào)查及感染病例的用藥分析 [J]. 抗感染藥學(xué), 2005; 2(3): 121-122, 127.
7. Tenover FC, Weigel LM, Appelbaum PC, et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania [J]. Antimicrob Agents Chemother, 2004; 48(1): 275-280.
8. Sibbald MJ, Ziebandt AK, Engelmann S, et al. Mapping the pathways to staphylococcal pathogenesis by comparative secretomics [J]. Microbiol Mol Biol Rev, 2006; 70(3): 755-788.
9. Noto MJ, Archer GL. A subset of Staphylococcus aureus strains harboring staphylococcal cassette chromosome mec (SCCmec) type Ⅳ is deficient in CcrAB-mediated SCCmec excision [J]. Antimicrob Agents Chemother, 2006; 50(8): 2782-2788.
10. Berger-Bchi B, Strssle A, Gustafson JE, et al. Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus [J]. Antimicrob Agents Chemother, 1992; 36(7): 1367-1373.
11. 李松， 肖桂元， 周甘平， 等. MRSA感染用藥分析 [J]. 現(xiàn)代醫(yī)院, 2008; 8(10): 19-21.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Fifteenth informational supplement [S]. Wayne, Pa., 2005: M100-S15.
13. Gould FK, Brindle R, Chadwick PR, et al. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom [J]. J Antimicrob Chemother, 2009; 63(5): 849-861.
14. Ferrara AM. Treatment of hospital-acquired pneumonia cau-sed by methicillin-resistant Staphylococcus aureus [J]. Int J Antimicrob Agents, 2007; 30(1): 19-24.
15. Gould IM. MRSA bacteraemia [J]. Int J Antimicrob Agen-ts, 2007; 30 Suppl 1: S66-S70.
  1. 1. Chambers HF. The changing epidemiology of Staphylococcus aureus? [J]. Emerg Infect Dis, 2001; 7(2): 178-182.
  2. 2. 汪復(fù)， 朱德妹， 胡付品， 等. 2008年中國(guó)CHINET細(xì)菌耐藥性監(jiān)測(cè) [J]. 中國(guó)感染與化療雜志, 2009; 9(5): 321-329.
  3. 3. 朱德妹， 汪復(fù)， 張嬰元. 2004年上海地區(qū)細(xì)菌耐藥性監(jiān)測(cè) [J]. 中國(guó)抗感染化療雜志, 2005; 5(4): 195-200.
  4. 4. 朱德妹， 張嬰元， 汪復(fù). 2006年上海地區(qū)細(xì)菌耐藥性監(jiān)測(cè) [J]. 中國(guó)感染與化療雜志, 2007; 7(6): 393-399.
  5. 5. Hope R, Livermore DM, Brick G, et al. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06 [J]. J Antimicrob Chemother, 2008; 62 Suppl 2: ii65-ii74.
  6. 6. 王琳， 時(shí)萍， 丁海燕， 等. 157株MRSA菌株的耐藥調(diào)查及感染病例的用藥分析 [J]. 抗感染藥學(xué), 2005; 2(3): 121-122, 127.
  7. 7. Tenover FC, Weigel LM, Appelbaum PC, et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania [J]. Antimicrob Agents Chemother, 2004; 48(1): 275-280.
  8. 8. Sibbald MJ, Ziebandt AK, Engelmann S, et al. Mapping the pathways to staphylococcal pathogenesis by comparative secretomics [J]. Microbiol Mol Biol Rev, 2006; 70(3): 755-788.
  9. 9. Noto MJ, Archer GL. A subset of Staphylococcus aureus strains harboring staphylococcal cassette chromosome mec (SCCmec) type Ⅳ is deficient in CcrAB-mediated SCCmec excision [J]. Antimicrob Agents Chemother, 2006; 50(8): 2782-2788.
  10. 10. Berger-Bchi B, Strssle A, Gustafson JE, et al. Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus [J]. Antimicrob Agents Chemother, 1992; 36(7): 1367-1373.
  11. 11. 李松， 肖桂元， 周甘平， 等. MRSA感染用藥分析 [J]. 現(xiàn)代醫(yī)院, 2008; 8(10): 19-21.
  12. 12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Fifteenth informational supplement [S]. Wayne, Pa., 2005: M100-S15.
  13. 13. Gould FK, Brindle R, Chadwick PR, et al. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom [J]. J Antimicrob Chemother, 2009; 63(5): 849-861.
  14. 14. Ferrara AM. Treatment of hospital-acquired pneumonia cau-sed by methicillin-resistant Staphylococcus aureus [J]. Int J Antimicrob Agents, 2007; 30(1): 19-24.
  15. 15. Gould IM. MRSA bacteraemia [J]. Int J Antimicrob Agen-ts, 2007; 30 Suppl 1: S66-S70.